Bridging the gap – estimation of 2022/2023 SARS-CoV-2 healthcare burden in Germany based on multidimensional data from a rapid epidemic panel
During the first two pandemic years, Germany lacked rapid adaptive population-based panels for epidemic diseases [1] as well as the capacity for central modelling platforms to quickly integrate information from cross-sectional surveys [2-4]. Instead, several population-specific and population-based seroprevalence studies were performed, and the results not published fast enough and rarely used in model estimates or scenarios [5]. Modelling groups operated independently without a central platform for harmonization and integration of results [6].
Source: International Journal of Infectious Diseases - Category: Infectious Diseases Authors: M Harries, V.K Jaeger, I Rodiah, M.J Hassenstein, J Ortmann, M Dreier, I von Holt, M Brinkmann, A Dulovic, D Gornyk, O Hovardovska, C Kuczewski, MA Kurosinski, M Schlotz, N Schneiderhan-Marra, M Strengert, G Krause, M Sester, F Klein, A Petersmann, A Karc Source Type: research
More News: Epidemics | Epidemiology | Germany Health | Infectious Diseases | Pandemics | SARS | Study